Purchases and Sales Made in Q1 2022 in Intra Cellular Therapies, Inc. (ITCI)
This table provides information about the institutional ownership of Intra Cellular Therapies, Inc. (ITCI) during Q1 2022. The information is specifically focused on institutions that hold shares of Intra-Cellular Therapies, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
May 12, 2023
Q1 2022
|
Norges Bank
Oslo, Q8 |
SELL
|
- |
-404K- 38.77% |
$15.6M - $25.1M
|
638K
$53.4M
|
|
|
May 06, 2022
Q1 2022
|
Times Square Capital Management, LLC
|
SELL
|
- |
-467K- 34.74% |
$18.1M - $29M
|
877K
$73.4M
|
|
|
May 09, 2022
Q1 2022
|
Norges Bank
Oslo, Q8 |
SELL
|
- |
-583KClosed |
$22.6M - $36.2M
|
0
$0
|
|
|
May 16, 2022
Q1 2022
|
Samlyn Capital, LLC
New York, NY |
SELL
|
- |
-626K- 56.38% |
$24.2M - $38.9M
|
484K
$40.5M
|
|
|
May 13, 2022
Q1 2022
|
Wasatch Advisors Inc
Salt Lake City, UT |
SELL
|
- |
-757K- 9.2% |
$29.3M - $47M
|
7.48M
$626M
|